Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Virology

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.71.8.5932-5941.1997PMID 9223483PMCID PMC191849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors.

  1997cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus Vectors

  1996cited by this paper
• Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction.

  1996cited by this paper
• Retroviral Vectors Efficiently Transduce Basal and Secretory Airway Epithelial Cells In Vitro Resulting in Persistent Gene Expression in Organotypic Culture

  1996cited by this paper
• Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein.

  1996cited by this paper
• Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

  1996cited by this paper
• Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

  1996cited by this paper
• Recombinant IL–12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung

  1995cited by this paper
• Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells

  1995cited by this paper
• Alveolar stem cell transduction by an adeno-associated viral vector.

  1995cited by this paper
• DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.

  1995cited by this paper
• Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway

  1995cited by this paper
• Adeno-associated virus vectors preferentially transduce cells in S phase.

  1994cited by this paper
• Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans

  1994cited by this paper
• DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors

  1994cited by this paper
• Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes.

  1994cited by this paper
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

  1994cited by this paper
• Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells.

  1994cited by this paper
• Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy

  1993cited by this paper
• Corrigendum: Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

  1993cited by this paper
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

  1993cited by this paper
• Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

  1993cited by this paper
• Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

  1993cited by this paper
• In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

  1992cited by this paper
• Use of adeno-associated virus as a general transduction vector for mammalian cells.

  1992cited by this paper
• Gene expression from adeno-associated virus vectors in airway epithelial cells.

  1992cited by this paper
• Reconstitution of tracheal grafts with a genetically modified epithelium.

  1991cited by this paper
• A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection.

  1991cited by this paper
• A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans.

  1990cited by this paper
• Site-specific integration by adeno-associated virus.

  1990cited by this paper
• Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.

  1990cited by this paper
• Site-specific integration by adeno-associated virus.

  1990cited by this paper
• Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

  1990cited by this paper
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper
• Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types

  1988cited by this paper
• Adeno-associated virus general transduction vectors: analysis of proviral structures

  1988cited by this paper
• Expression of active, membrane-bound human placental alkaline phosphatase by transfected simian cells.

  1987cited by this paper
• [Toxicity studies of VP 16-213 (I)--Acute toxicity in mice, rats and rabbits].

  1986cited by this paper
• An Escherichia coli recBCsbcBrecF host permits the deletion-resistant propagation of plasmid clones containing the 5'-terminal palindrome of minute virus of mice.

  1985cited by this paper
• T. Maniatis, E. F. Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, X + 545 S., 61 Abb., 28 Tab. Cold Spring Harbor, N. Y. 1982. Cold Spring Harbor Laboratory

  1984cited by this paper
• Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.

  1984cited by this paper
• Distribution of nonciliated bronchiolar epithelial (Clara) cells in intra- and extrapulmonary airways of the rabbit.

  1983cited by this paper
• Carcinogenesis and aging. III. The role of age in initiation and promotion of carcinogenesis.

  1982cited by this paper
• Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.

  1982cited by this paper
• Cell proliferation in the mammalian lung.

  1980cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper

• Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group

  2025cites this paper
• The Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs)

  2024cites this paper
• Modulation of AAV transduction and integration targeting by topoisomerase poisons

  2024cites this paper
• Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results

  2024cites this paper
• Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies

  2024cites this paper
• Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy

  2024cites this paper
• Cryo-electron Microscopy of Adeno-associated Virus

  2022cites this paper
• An artificial virus-like triblock protein shows low in vivo humoral immune response and high stability.

  2021cites this paper
• Repeated Systemic Dosing of Adeno-Associated Virus Vectors in Immunocompetent Mice After Blockade of T Cell Costimulatory Pathways

  2021cites this paper
• New Directions in Pulmonary Gene Therapy

  2020cites this paper
• Development of Gene Therapy Vectors: Remaining Challenges.

  2020cites this paper
• Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease

  2020cites this paper
• Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes

  2020cites this paper
• Emerging gene therapies for cystic fibrosis

  2019cites this paper
• Emerging Therapies for Cystic Fibrosis

  2019cites this paper
• Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A

  2019cites this paper
• Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates.

  2019cites this paper
• Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?

  2019cites this paper
• Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia

  2019cites this paper
• Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward

  2018cites this paper
• Elucidation of the Tissue Tropism Determinants of Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus

  2018cites this paper
• Analytical approaches to characterize AAV vector production & purification: Advances and challenges

  2018cites this paper
• Immunomodulatory, liver depot gene therapy for Pompe disease.

  2017cites this paper
• Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep

  2017cites this paper
• Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5ch and AAV1.

  2017cites this paper
• Manufacturing of recombinant adeno‐associated viruses using mammalian expression platforms

  2017cites this paper
• Preclinical models to assess the immunogenicity of AAV vectors.

  2017cites this paper
• Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens

  2016cites this paper
• In vivo tissue-tropism of adeno-associated viral vectors.

  2016cites this paper
• Progress and prospects of gene therapy clinical trials for the muscular dystrophies.

  2016cites this paper
• Aalborg Universitet Characterization of endorphin gene expression following electroporation in mice tibialis anterior muscle

  2015cites this paper
• Adeno-associated Virus Vector as a Tool for the Analysis of in vivo Ovine Betaretroviral Gene Expression, and its use as a Vector for Therapeutic Gene Delivery

  2015cites this paper
• Enhanced Efficacy from Gene Therapy in Pompe Disease Using Coreceptor Blockade

  2015cites this paper
• Searching for a cure for cystic fibrosis. A 25-year quest in a nutshell

  2015cites this paper
• Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy

  2015cites this paper
• Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application

  2015cites this paper
• Characterization of Endorphin Gene Expression Following Electroporation in Mice Tibialis Anterior Muscle: Implications for Gene Doping Detection

  2015cites this paper
• smooth muscle cells in vivo Adeno-associated virus vector transduction of vascular

  2015cites this paper
• Characterization of endorphin gene expression following electroporation in mice tibialis anterior muscle

  2015cites this paper
• Targeting the Root Cause of Cystic Fibrosis.

  2015cites this paper
• Investigation and application of novel adeno-associated viral vectors for Cystic Fibrosis gene therapy

  2015cites this paper
• Systematic Comparison and Validation of Quantitative Real-Time PCR Methods for the Quantitation of Adeno-Associated Viral Products

  2015cites this paper
• Preclinical Development of New Therapy for Glycogen Storage Diseases.

  2015cites this paper
• Complement yourself: transcomplementation rescues partially folded mutant proteins

  2014cites this paper
• Immunological Ignorance Allows Long-Term Gene Expression After Perinatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer to Murine Airways

  2014cites this paper
• Evaluating Properties of Dystrophin and Delivery Methods of rAAV Gene Therapy for Duchenne Muscular Dystrophy

  2014cites this paper
• Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression

  2014cites this paper
• Understanding mechanisms of Adeno-associated virus vector transduction through pharmacological and biological approaches

  2014cites this paper
• Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates

  2014cites this paper
• Systemic RNAi Delivery to the Muscles of ROSA26 Mice Reduces lacZ Expression

  2014cites this paper
• Outcome measures for cystic fibrosis gene therapy clinical trials

  2013cites this paper
• Modulation of gene expression by chronic stress in astroglia in hippocampus and prefrontal cortex of the rat

  2012cites this paper
• Pseudotyped AAV Vector-Mediated Gene Transfer in a Human Fetal Trachea Xenograft Model: Implications for In Utero Gene Therapy for Cystic Fibrosis

  2012cites this paper
• Modulation of gene expression by chronic stress in astroglia in hippocampus and prefrontal cortex of the rat

  2012cites this paper
• Vector Specific Tolerance Induction for Airwary Gene Therapy

  2012cites this paper
• Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20.

  2012cites this paper
• Limitations of Encapsidation of Recombinant Self-Complementary Adeno-Associated Viral Genomes in Different Serotype Capsids and Their Quantitation

  2012cites this paper
• Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia

  2012cites this paper
• Gene augmentation trials using the Rpe65-deficient dog: contributions towards development and refinement of human clinical trials.

  2012cites this paper
• Towards a structural understanding of adeno- associated virus serotype 2 and its recognition by antibodies

  2012cites this paper
• Progress in gene and cell therapy for cystic fibrosis lung disease.

  2012cites this paper
• Adeno-Associated Virus Vector Mediated Expression of an Oncogenic Retroviral Envelope Protein Induces Lung Adenocarcinomas in Immunocompetent Mice

  2012cites this paper
• Strategies for improving adeno-associated viral infection of airway epithelial cells

  2012cites this paper
• Single Amino Acid Modification of Adeno-Associated Virus Capsid Changes Transduction and Humoral Immune Profiles

  2012cites this paper
• Single Amino Acid Modification of Adeno-Associated Virus Capsid Changes Transduction and Humoral Immune Profiles

  2012cites this paper
• Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response.

  2011cites this paper
• AAV6-mediated Systemic shRNA Delivery Reverses Disease in a Mouse Model of Facioscapulohumeral Muscular Dystrophy

  2011cites this paper
• Current Status and Future Directions of Gene and Cell Therapy for Cystic Fibrosis

  2011cites this paper
• AAV 6-mediated Systemic shRNA Delivery Reverses Disease in a Mouse Model of Facioscapulohumeral Muscular Dystrophy

  2011cites this paper
• Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia

  2011cites this paper
• A recombinant myeloid-binding adenovirus for targeted pulmonary gene therapy

  2011cites this paper
• Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus Promoters Drive Gene Expression in All Airway Epithelial Cells of Mice but Only Induce Tumors in the Alveolar Region of the Lungs

  2011cites this paper
• Strategies to increase gene transfer to the lung

  2011cites this paper
• Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6).

  2011cites this paper
• Gene therapy in the second eye of RPE65-deficient dogs improves retinal function

  2011cites this paper
• Exploiting natural diversity of AAV for the design of vectors with novel properties.

  2011cites this paper
• Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials

  2011cites this paper
• Gene therapy for cystic fibrosis lung disease

  2011cites this paper
• Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods

  2011cites this paper
• Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production

  2010cites this paper
• Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia

  2010cites this paper
• Efficient, specific and targeted delivery of genes to the lung.

  2010cites this paper
• Expression of Human α1-Antitrypsin in Mice and Dogs Following AAV6 Vector-mediated Gene Transfer to the Lungs.

  2010cites this paper
• The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.

  2010cites this paper
• Viral vectors for cystic fibrosis gene therapy: What does the future hold?

  2010cites this paper
• Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.

  2010cites this paper
• Liver-directed gene expression using recombinant AAV 2/8 vectors--a tolerogenic strategy for gene delivery?

  2010cites this paper
• Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

  2009cites this paper
• Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP 1

  2009cites this paper
• Functional Cystic Fibrosis Transmembrane Conductance Regulator Expression in Cystic Fibrosis Airway Epithelial Cells by AAV6.2-Mediated Segmental Trans-Splicing

  2009cites this paper
• Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy.

  2009cites this paper
• Cystic fibrosis gene therapy: successes, failures and hopes for the future

  2009cites this paper
• Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.

  2009cites this paper
• Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects

  2009cites this paper
• Does the use of recombinant AAV5 in pulmonary gene therapy lead to lung damage?

  2009cites this paper
• Identification of ebola glycoprotein mutants that exhibit increased transduction efficiency

  2009cites this paper
• rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.

  2009cites this paper
• Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye

  2009cites this paper
• Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1

  2009cites this paper
• Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential

  2008cites this paper